Grants / Department of Health and Human Services / National Institutes of Health

PAR-22-173: Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closed Closed November 4, 2024 Opportunity PAR-22-173 ☆ Save

This grant is closed. A newer notice from the same program is open now: Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) (PAR-25-104). Status: Due dates in the notice, expires October 25, 2027. It is in our archive of National Institutes of Health notices from 2022.

• Award ceiling$600,000
• Cost sharingNot required
• Funding typeGrant

Key dates

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

• Projects NIH funded under this notice had a median yearly award of $290,052; it allows up to $600,000 per award.
• Most of the program's money (64% over five years) went to nonprofits.
• No cost sharing or match is required.

What the grant funds

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.

Category: Education, Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PAR-25-104, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.